Cardiac dysfunction in CF is not only a complication of pulmonary hypertension caused by the destruction of lung parenchyma but also additional factors, such as CFTR gene polymorphism, hypoxia-induced myocardial damage, systemic inflammation, diabetic cardiomyopathy, and deficiency of some essential trophic factors. This evidence concerns the gene CFTR and pulmonary hypertension.